Total Payments
$8,404
2024 Payments
$1,972
Companies
39
Transactions
478
Medicare Patients
4,131
Medicare Billing
$824,492
Payment Breakdown by Category
Food & Beverage$8,385 (99.8%)
Education$18.96 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,385 | 476 | 99.8% |
| Education | $18.96 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,108 | 69 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $915.50 | 78 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $813.95 | 28 | $0 (2024) |
| Alkermes, Inc. | $578.99 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $485.35 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $456.92 | 22 | $0 (2024) |
| Lundbeck LLC | $410.70 | 24 | $0 (2024) |
| Allergan, Inc. | $395.78 | 30 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $384.64 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $300.14 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,972 | 96 | ABBVIE INC. ($327.12) |
| 2023 | $1,509 | 86 | ABBVIE INC. ($404.07) |
| 2022 | $894.52 | 45 | ABBVIE INC. ($186.05) |
| 2021 | $1,246 | 66 | AbbVie Inc. ($191.00) |
| 2020 | $1,154 | 74 | Sunovion Pharmaceuticals Inc. ($323.94) |
| 2019 | $1,132 | 62 | Sunovion Pharmaceuticals Inc. ($227.34) |
| 2018 | $41.54 | 2 | Scilex Pharmaceuticals Inc. ($22.02) |
| 2017 | $455.71 | 47 | Sunovion Pharmaceuticals Inc. ($193.76) |
All Payment Transactions
478 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: CNS | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/25/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ADHD | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ADHD | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: ADHD | ||||||
| 10/09/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Neurology | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,034 | 2,481 | $448,830 | $198,895 |
| 2022 | 11 | 819 | 2,332 | $413,575 | $176,000 |
| 2021 | 11 | 1,142 | 3,408 | $570,860 | $244,056 |
| 2020 | 13 | 1,136 | 2,957 | $501,440 | $205,541 |
Total Patients
4,131
Total Services
11,178
Medicare Billing
$824,492
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 80 | 573 | $143,250 | $59,952 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 427 | $74,725 | $37,680 | 50.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 240 | 472 | $70,800 | $28,910 | 40.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 144 | 145 | $36,250 | $19,370 | 53.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 80 | 344 | $46,440 | $18,561 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 59 | $11,800 | $7,819 | 66.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 56 | 56 | $14,000 | $7,706 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 96 | $11,520 | $5,895 | 51.2% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 23 | 75 | $11,250 | $5,621 | 50.0% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 34 | 35 | $7,175 | $4,360 | 60.8% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 16 | 16 | $3,600 | $2,470 | 68.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 59 | 131 | $11,520 | $449.97 | 3.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 38 | 52 | $6,500 | $102.50 | 1.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 275 | 1,176 | $176,400 | $63,783 | 36.2% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 63 | 359 | $89,750 | $37,250 | 41.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 184 | 189 | $47,250 | $25,467 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 211 | $36,925 | $18,162 | 49.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 36 | 193 | $26,055 | $10,283 | 39.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 35 | 35 | $8,750 | $5,028 | 57.5% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 28 | 28 | $6,425 | $4,192 | 65.2% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 34 | 52 | $7,280 | $3,569 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 21 | $4,200 | $2,844 | 67.7% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 22 | 22 | $4,510 | $2,653 | 58.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 29 | $3,480 | $1,662 | 47.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 12 | 17 | $2,550 | $1,107 | 43.4% |
About Dr. Ernest Graypel, MD
Dr. Ernest Graypel, MD is a Psychiatry healthcare provider based in St Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1265723407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ernest Graypel, MD has received a total of $8,404 in payments from pharmaceutical and medical device companies, with $1,972 received in 2024. These payments were reported across 478 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($8,385).
As a Medicare-enrolled provider, Graypel has provided services to 4,131 Medicare beneficiaries, totaling 11,178 services with total Medicare billing of $824,492. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location St Louis, MO
- Active Since 04/21/2011
- Last Updated 09/30/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1265723407
Products in Payments
- VRAYLAR (Drug) $1,484
- LATUDA (Drug) $915.50
- INGREZZA (Drug) $813.95
- CAPLYTA (Drug) $505.21
- REXULTI (Drug) $478.71
- TRINTELLIX (Drug) $435.89
- SPRAVATO (Drug) $321.72
- ARISTADA (Drug) $297.88
- LYBALVI (Drug) $220.58
- NUEDEXTA (Drug) $215.41
- AUSTEDO (Drug) $204.43
- BELSOMRA (Drug) $198.19
- Fanapt (Drug) $190.91
- APLENZIN (Drug) $165.74
- HETLIOZ (Drug) $161.91
- Zubsolv (Drug) $151.36
- BRINTELLIX (Drug) $135.76
- INVEGA SUSTENNA (Drug) $118.49
- Dyanavel XR (Drug) $90.03
- LUCEMYRA (Drug) $89.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in St Louis
Dr. Thomas Nowotny, Md, MD
Psychiatry — Payments: $22,748
Psychiatry $22,748
Sofia Grewal, Md, MD
Psychiatry — Payments: $6,606
Psychiatry $6,606
Dr. Dale Anderson, M.d, M.D
Psychiatry — Payments: $5,106
Psychiatry $5,106
Srinivas Chilakamarri, Md, MD
Psychiatry — Payments: $932.83
Psychiatry $932.83
Dr. Ahmad Ardekani, Md, MD
Psychiatry — Payments: $328.74
Psychiatry $328.74
Dr. Garry Vickar, Md, MD
Psychiatry — Payments: $101.19
Psychiatry $101.19